Technical Analysis for PRTG - Portage Biotech Inc.

Grade Last Price % Change Price Change
F 0.58 4.55% 0.03
PRTG closed up 4.55 percent on Monday, March 18, 2024, on 31 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish 4.55%
Calm After Storm Range Contraction 4.55%
Narrow Range Bar Range Contraction 4.55%
Wide Bands Range Expansion 4.55%
Gapped Up Strength 4.55%
Fell Below 20 DMA Bearish 4.55%

   Recent Intraday Alerts

Alert Time
20 DMA Resistance about 14 hours ago
Rose Above 20 DMA about 15 hours ago
Rose Above Previous Day's High about 15 hours ago
Rose Above 10 DMA about 15 hours ago
Up 5% about 15 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Portage Biotech Inc. Description

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunology Solid Tumors Immune System Antibodies Antiviral Drug Interferon Biotechnology Products Acute Kidney Injury Natural Killer T Cell

Is PRTG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.4
52 Week Low 0.34
Average Volume 60,474
200-Day Moving Average 2.00
50-Day Moving Average 0.74
20-Day Moving Average 0.57
10-Day Moving Average 0.56
Average True Range 0.12
RSI (14) 44.75
ADX 12.36
+DI 24.34
-DI 17.55
Chandelier Exit (Long, 3 ATRs) 0.44
Chandelier Exit (Short, 3 ATRs) 0.69
Upper Bollinger Bands 0.70
Lower Bollinger Band 0.44
Percent B (%b) 0.53
BandWidth 45.27
MACD Line -0.05
MACD Signal Line -0.07
MACD Histogram 0.0156
Fundamentals Value
Market Cap 11.37 Million
Num Shares 19.8 Million
EPS -6.93
Price-to-Earnings (P/E) Ratio -0.08
Price-to-Sales 0.00
Price-to-Book 0.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.73
Resistance 3 (R3) 0.73 0.69 0.70
Resistance 2 (R2) 0.69 0.65 0.69 0.69
Resistance 1 (R1) 0.63 0.63 0.66 0.63 0.68
Pivot Point 0.59 0.59 0.61 0.59 0.59
Support 1 (S1) 0.53 0.55 0.56 0.53 0.47
Support 2 (S2) 0.49 0.53 0.49 0.46
Support 3 (S3) 0.43 0.49 0.45
Support 4 (S4) 0.43